Search bioRxiv⌕ Search

Biology subjects

Aldea, R.

Publications and source records attributed to Aldea, R..

2 recordsLinked to original sources

Harmonizing amyloid PET tracers at the local level: evaluation of regional Centiloid equations

INTRODUCTION: The Centiloid (CL) framework standardizes global amyloid-PET across radiotracers. While global scaling remains essential for participant selection, amyloid-targeting therapies require quantifying localized plaque removal. However, applying global equations regionally introduces systematic bias, particularly in subcortical structures where off-target binding alters non-specific background. METHODS: We extended the Centiloid framework regionally and voxel-wise using GAAIN datasets: Level-1 ([11C]PiB) and Level-2 paired [11C]PiB and fluorinated head-to-head cohorts ([18F]florbetaben, [18F]florbetapir, [18F]flutemetamol, and [18F]NAV4694). Level-1 defines the regional Centiloid scale using region-specific intercepts while fixing the global slope. Level-2 calibrates fluorinated tracer uptake to reference [11C]PiB SUVR using linear equations. We compared three slope-intercept models (Global, Regional-Intercept, and Regional) using information criteria and Mean Absolute Error (MAE). RESULTS: Regional-Intercept model was identified as optimal across all four radiotracers. In neocortical regions, Global and Regional-Intercept models showed high agreement across canonical lobes. In deep gray matter, global equations introduced large systematic offsets, with mean absolute conversion errors in the pallidum reaching 27.7 to 45.6 CL. The Regional-Intercept model eliminated this bias, reducing subcortical MAE on average below 15 CL while preserving a unified biological scale. DISCUSSION: Applying global Centiloid equations directly to regions introduces substantial bias in subcortical regions. With the Regional-Intercept model, the same Centiloid value corresponds to the same amyloid concentration across brain regions and radiotracers. This provides a reliable basis for cross- sectional regional evaluation, multi-tracer cohort pooling, tracking regional clearance, and mapping regional progression in clinical research.

neuroscience↗

Dynamical Aβ-Tau-Neurodegeneration Model Predicts Alzheimer's Disease Mechanisms and Biomarker Progression

Alzheimers disease is characterised by the pathological interaction of two proteins, amyloid-beta (A{beta}) and tau, which collectively drive neurodegeneration and cognitive decline. The progression of A{beta}, tau, and neurodegeneration biomarkers is captured by the ATN framework, which is a powerful tool for disease classification. However, since the ATN framework is mainly descriptive, it cannot quantify or predict relationships between biomarkers over time. We address this limitation by introducing a dynamical ATN (dATN) model that mechanistically simulates the spatiotemporal progression of A{beta}, tau, and neurodegeneration. The dATN model integrates mechanisms of prion-like protein aggregation of A{beta} and tau, network-based tau propagation, A{beta}-driven catalysis of tau progression, and tau-driven neurodegeneration. We calibrated the model using multimodal longitudinal imaging data from both the ADNI and BioFINDER-2 cohorts and show that it accurately fits longitudinal regional A{beta}, tau, and neurodegeneration data. Using the dATN model, we show that A{beta}-induced effects predict Braak-like cortical tau progression, that the spatial colocalisation of A{beta} and tau is a crucial biomarker of disease acceleration, and that tau-driven atrophy strongly correlates with observed neurodegeneration. Furthermore, by integrating the disease progression model with pharmacokinetic-pharmacodynamic simulations, we present a powerful tool that facilitates regional evaluation of therapeutic strategies targeting A{beta}, identification of critical intervention windows, and prediction of heterogeneous treatment effects across brain regions. This framework unifies mechanistic understanding with clinical imaging biomarkers, offering a quantitative approach for forecasting disease progression, testing mechanistic hypotheses, and optimising personalised treatment strategies in AD. One Sentence SummaryColocalisation of A{beta} and tau predicts regional tau progression and optimal A{beta}-targeted intervention windows, while tau predicts neurodegeneration.

neuroscience↗